Atlas Trials

Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness

Clinical trial NCT05078671 · UNKNOWN

Trial details

NCT number
NCT05078671
Sponsor
Radboud University Medical Center
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Cancer
Start date
2021-12-15
Primary completion
2025-12-31
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.